Enhabit SG&A Expenses 2020-2024 | EHAB
Enhabit sg&a expenses from 2020 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Enhabit Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $442 |
| 2022 | $415 |
| 2021 | $413 |
| 2020 | $398 |
| 2019 | $466 |
| Enhabit Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-03-31 | $108 |
| 2023-12-31 | $115 |
| 2023-09-30 | $109 |
| 2023-06-30 | $108 |
| 2023-03-31 | $111 |
| 2022-12-31 | $105 |
| 2022-09-30 | $108 |
| 2022-06-30 | $102 |
| 2022-03-31 | $101 |
| 2021-12-31 | $103 |
| 2021-09-30 | $104 |
| 2021-06-30 | $106 |
| 2021-03-31 | $100 |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.461B | $1.046B |
| Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $117.915B | 14.80 |
| Cencora (COR) | United States | $43.985B | 17.15 |
| ICON (ICLR) | Ireland | $26.639B | 25.15 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $16.031B | 23.60 |
| CochLear (CHEOY) | Australia | $13.625B | 0.00 |
| Natera (NTRA) | United States | $13.523B | 0.00 |
| Revvity (RVTY) | United States | $13.368B | 23.45 |
| Viatris (VTRS) | United States | $12.478B | 3.73 |
| Medpace Holdings (MEDP) | United States | $11.950B | 39.32 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.358B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.803B | 20.68 |
| Solventum (SOLV) | United States | $10.078B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.710B | 0.00 |
| HealthEquity (HQY) | United States | $6.884B | 50.72 |
| Bausch + Lomb (BLCO) | Canada | $5.410B | 21.68 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Doximity (DOCS) | United States | $5.177B | 36.04 |
| PACS (PACS) | United States | $4.499B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.467B | 31.72 |
| Life Times (LTH) | United States | $3.279B | 34.35 |
| Sotera Health (SHC) | United States | $3.139B | 15.40 |
| GoodRx Holdings (GDRX) | United States | $2.837B | 108.00 |
| Agilon Health (AGL) | United States | $2.566B | 0.00 |
| Progyny (PGNY) | United States | $2.535B | 43.64 |
| NovoCure (NVCR) | Jersey | $2.397B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.064B | 8.18 |
| Premier (PINC) | United States | $1.985B | 8.49 |
| BrightSpring Health Services (BTSG) | United States | $1.962B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.915B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.507B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.420B | 0.00 | |
| Embecta (EMBC) | United States | $0.717B | 4.87 |
| CareDx (CDNA) | United States | $0.704B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.619B | 6.57 |
| InnovAge Holding (INNV) | United States | $0.589B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| GeneDx Holdings (WGS) | United States | $0.533B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.507B | 0.00 |
| ModivCare (MODV) | United States | $0.403B | 7.54 |
| Sonida Senior Living (SNDA) | United States | $0.383B | 0.00 |
| LifeMD (LFMD) | United States | $0.359B | 0.00 |
| MultiPlan (MPLN) | United States | $0.348B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.324B | 0.00 |
| Sharecare (SHCR) | United States | $0.306B | 0.00 |
| DocGo (DCGO) | United States | $0.300B | 16.39 |
| Beauty Health (SKIN) | United States | $0.270B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.223B | 0.00 |
| Biodesix (BDSX) | United States | $0.155B | 0.00 |
| So-Young (SY) | China | $0.104B | 52.50 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.71 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Oncology Institute (TOI) | United States | $0.035B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| OncoCyte (OCX) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| OpGen (OPGN) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |